Wuxi Sinotide New Drug Discovery Institutes 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MSC-IFNα / Wuxi Sinotide New Drug Discovery Institutes, Chinese PLA General Hospital
NCT05699811: IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

Recruiting
1/2
40
RoW
MSC-IFNα, Nab paclitaxel, Abraxane, Cyclophosphamide, Anti-PD-1 monoclonal antibody, Toripalimab Injection, Sintilimab Injection, Camrelizumab Injection, Tislelizumab Injection
Chinese PLA General Hospital, Wuxi Sinotide New Drug Discovery Institutes
Locally Advanced or Metastatic Solid Tumors
12/25
12/26

Download Options